Albuminuria

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Family Investigation of Nephropathy and Diabetes (F.I.N.D.)

  The Family Investigation of Nephropathy and Diabetes (F.I.N.D.) trial registry entry describes an NIDDK-supported study on diabetic nephropa…

• CLINICAL_TRIALS research · 2025-09-16
  Clinical Trial Update: Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin [Phase 2]

  A Phase 2 clinical trial evaluating empagliflozin, an SGLT2 inhibitor, for sickle cell–related kidney disease in patients with sickle cell a…

• CLINICAL_TRIALS research · 2025-09-15
  Clinical Trial Update: Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome [NA]

  This clinical trial update from Universidade do Porto reports ongoing recruitment for a study evaluating the effects of algae on cardiovascu…

• CLINICAL_TRIALS research · 2023-05-09
  Clinical Trial Update: Evaluation of the Accuracy and Usability of the ACR | U.S. Urine Analysis Test System in the Lay User Hands [NA]

  A completed clinical trial evaluating the accuracy and usability of the ACR | U.S. Urine Analysis Test System for detecting albuminuria in l…

• CLINICAL_TRIALS research · 2019-08-19
  Clinical Trial Update: Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria [Phase 4]

  Phase 4 trial update examining renal effects of empagliflozin alone or with semaglutide in people with type 2 diabetes and albuminuria.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2008-01-03
  Clinical Trial Update: Aldosterone and Vascular Disease in Diabetes Mellitus [NA]

  A completed Brigham and Women's Hospital clinical trial examining the role of aldosterone in vascular disease among individuals with diabete…